Specialty code 183500000X · Sacramento, CA
NPI
1063936342
Since 2017
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2345 Fair Oaks Blvd
Sacramento, CA, 95825
Phone (916) 480-7054
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$403K
2,407 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Leila I Munoz prescribed most often to Medicare patients was Atorvastatin Calcium, with 328 prescriptions and refills. In total Leila I Munoz wrote 2,407 Medicare prescriptions that cost $403K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 328 | 1,086 | 120 | $3,937 |
| Glipizide Generic | 244 | 804 | 99 | $3,445 |
| Metformin Hcl Er Metformin Hcl | 201 | 655 | 82 | $2,058 |
| Ozempic Semaglutide | 192 | 201 | 33 | $146K |
| Humulin N Insulin Nph Human Isophane | 140 | 414 | 55 | $23K |
| Metformin Hcl Generic | 131 | 435 | 57 | $1,692 |
| Jardiance Empagliflozin | 118 | 385 | 43 | $82K |
| Lisinopril Generic | 83 | 274 | 33 | $1,015 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 81 | 245 | 35 | $2,220 |
| Humulin R Insulin Regular, Human | 80 | 243 | 31 | $17K |
| Insulin Glargine-Yfgn Generic | 74 | 202 | 38 | $9,571 |
| Glipizide Er Glipizide | 66 | 196 | 22 | $1,800 |
| Amlodipine Besylate Generic | 57 | 190 | 20 | $692 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 51 | 128 | 20 | $7,918 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 48 | 134 | 25 | $1,207 |
Brand drugs: 811 claims; generic drugs: 1,386 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Leila I Munoz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.